Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients
2018
Details
Title
Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients
Author(s)
Homicsko, K. ; Richtig, G. ; Tuchmann, F. ; Tsourti, Z. ; Hanahan, D. ; Coukos, G. ; Wind-Rotolo, M. ; Richtig, E. ; Zygoura, P. ; Holler, C. ; Dafni, U. ; Michielin, O. A.
Published in
Annals Of Oncology
Volume
29
Pages
40-40
Conference
ESMO Immuno-Oncology Congress, Geneva, SWITZERLAND, Dec 13-16, 2018
Date
2018-12-01
Publisher
Oxford, OXFORD UNIV PRESS
ISSN
0923-7534
1569-8041
1569-8041
Other identifier(s)
View record in Web of Science
Laboratories
CMSO
Record Appears in
Scientific production and competences > SV - School of Life Sciences > ISREC - Swiss Institute for Experimental Cancer Research > CMSO - Merck Serono Chair in Oncology
Peer-reviewed publications
Conference Papers
Work produced at EPFL
Published
Peer-reviewed publications
Conference Papers
Work produced at EPFL
Published
Record creation date
2019-06-18